These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21619607)

  • 41. Hope, disappointment and perseverance: Reflections of people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study.
    Lacerda EM; McDermott C; Kingdon CC; Butterworth J; Cliff JM; Nacul L
    Health Expect; 2019 Jun; 22(3):373-384. PubMed ID: 30632248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study.
    Słomko J; Newton JL; Kujawski S; Tafil-Klawe M; Klawe J; Staines D; Marshall-Gradisnik S; Zalewski P
    BMJ Open; 2019 Mar; 9(3):e023955. PubMed ID: 30850404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta.
    Nijs J; Van Oosterwijck J; Meeus M; Lambrecht L; Metzger K; Frémont M; Paul L
    J Intern Med; 2010 Apr; 267(4):418-35. PubMed ID: 20433584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a functional ability scale for children and young people with myalgic encephalopathy (ME)/chronic fatigue syndrome (CFS).
    Moss J
    J Child Health Care; 2005 Mar; 9(1):20-30. PubMed ID: 15684437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in Australian primary care patients: only part of the story?
    Orji N; Campbell JA; Wills K; Hensher M; Palmer AJ; Rogerson M; Kelly R; de Graaff B
    BMC Public Health; 2022 Aug; 22(1):1516. PubMed ID: 35945527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The financial and psychological impacts on mothers of children with chronic fatigue syndrome (CFS/ME).
    Missen A; Hollingworth W; Eaton N; Crawley E
    Child Care Health Dev; 2012 Jul; 38(4):505-12. PubMed ID: 21880054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comorbidity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study.
    Castro-Marrero J; Faro M; Aliste L; Sáez-Francàs N; Calvo N; Martínez-Martínez A; de Sevilla TF; Alegre J
    Psychosomatics; 2017; 58(5):533-543. PubMed ID: 28596045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impaired Health-Related Quality of Life in Adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Impact of Core Symptoms.
    Roma M; Marden CL; Flaherty MAK; Jasion SE; Cranston EM; Rowe PC
    Front Pediatr; 2019; 7():26. PubMed ID: 30828572
    [No Abstract]   [Full Text] [Related]  

  • 51. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study.
    Van Oosterwijck J; Nijs J; Meeus M; Lefever I; Huybrechts L; Lambrecht L; Paul L
    J Intern Med; 2010 Sep; 268(3):265-78. PubMed ID: 20412374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Fenouillet E; Vigouroux A; Steinberg JG; Chagvardieff A; Retornaz F; Guieu R; Jammes Y
    J Transl Med; 2016 Aug; 14(1):251. PubMed ID: 27580693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Problems in defining post-exertional malaise.
    Jason LA; Evans M; So S; Scott J; Brown A
    J Prev Interv Community; 2015; 43(1):20-31. PubMed ID: 25584525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
    Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
    Strassheim VJ; Sunnquist M; Jason LA; Newton JL
    BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.
    Rowe PC; Underhill RA; Friedman KJ; Gurwitt A; Medow MS; Schwartz MS; Speight N; Stewart JM; Vallings R; Rowe KS
    Front Pediatr; 2017; 5():121. PubMed ID: 28674681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
    Toogood PL; Clauw DJ; Phadke S; Hoffman D
    Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptoms of chronic fatigue syndrome/myalgic encephalopathy are not determined by activity pacing when measured by the chronic pain coping inventory.
    Thompson DP; Antcliff D; Woby SR
    Physiotherapy; 2018 Mar; 104(1):129-135. PubMed ID: 28843450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
    Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased Vulnerability to Pattern-Related Visual Stress in Myalgic Encephalomyelitis.
    Wilson RL; Paterson KB; Hutchinson CV
    Perception; 2015 Dec; 44(12):1422-6. PubMed ID: 26562880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.